Pure Solutions

Pure provides solutions. Whether it’s creating therapeutics for immunotherapy, pioneering an approach to producing highly purified forms of HLA proteins, or developing vaccines for combating cancer, we’re leading the way to harnessing the power of the human immune system.

Pure Therapeutics

Harnessing HLA to create groundbreaking therapeutic tools.

Pure’s scientists harness the important biological mechanisms of HLA to develop therapeutics for immunotherapy. Based on extensive research of the natural degradation and processing of HLA Class I in human cells and the extracellular mechanisms of HLA Class II, Pure is developing groundbreaking tools to discover biomarkers that mark infected cells. Utilizing these biomarkers, we are developing monoclonal antibody therapies and T-cell eliciting vaccines to combat cancer and infectious diseases.